A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma Patient
Clinical trial NCT07649395 · COMPLETED
Trial details
- NCT number
- NCT07649395
- Sponsor
- Mei Feng
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2024-06-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.